Gallant Therapeutics

Gallant Therapeutics

Biotechnology Research

SAN DIEGO, CA 1,305 followers

Setting a New Standard in Animal Health🐾 Harnessing the Power of Stem Cell Therapy to Treat the Root Cause of Diseases

About us

Gallant Therapeutics is a clinical-stage animal health biotechnology company setting a new standard in animal health by harnessing the power of stem cell therapy to treat the root cause of diseases in dogs and cats. Our pipeline of off-the-shelf mesenchymal stem cell (MSC) therapies has the potential to treat a broad range of diseases, including canine and feline osteoarthritis (OA), feline chronic kidney disease (CKD), and others. The first product based on our uterine-derived platform for feline chronic gingivostomatitis (FCGS), is on track for conditional approval by the FDA in 2025. United by a love of and commitment to animals, Gallant’s team includes industry pioneers in veterinary regenerative medicine with deep experience in cell therapy product development, manufacturing and commercialization.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
SAN DIEGO, CA
Type
Privately Held
Founded
2018

Locations

Employees at Gallant Therapeutics

Updates

Similar pages

Browse jobs